版本:
中国

BRIEF-Avadel Pharmaceuticals files for non-timely 10-K

March 16 Avadel Pharmaceuticals Plc

* Files for non-timely 10-K - SEC filing

* Avadel Pharmaceuticals - expects to file annual report on form 10-K within the extension period of 15 calendar days as provided under rule 12B-25

* Avadel Pharmaceuticals - expects to report total revenues of about $150 million for 2016 versus total revenues of about $173 million for 2015

* Avadel Pharmaceuticals - expects to report net loss of about $41 million for 2016 versus net income of about $42 million for 2015 Source: (bit.ly/2mxzb5w) Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐